Down 76% This Year, Is This Growth Stock Now a Screaming Buy?
When shares of innovative growth stocks like Ginkgo Bioworks (NYSE: DNA) plummet, cunning investors know that there could be opportunity in the air. So even if a company like Ginkgo is down by more than 76% in 2022, it's a good time to take a closer look.
In fact, there are a few reasons to believe that now is a great time to start a position in the stock for the purpose of a long-term hold. Here's why Ginkgo's big ambitions are already being realized, and why shareholders are likely to benefit in the years to come.
The biggest reason that Ginkgo is an attractive buy is that it benefits enormously from economies of scale in its manufacturing. While it isn't currently profitable, that probably won't be true forever, and here's why.
Source Fool.com
